Nabriva Therapeutics plc
NBRVF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57 | -$49 | -$69 | -$83 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $3 | $0 |
| Stock-Based Comp. | $2 | $3 | $5 | $10 |
| Change in WC | $14 | -$15 | -$11 | -$0 |
| Other Non-Cash | $5 | $1 | $1 | $1 |
| Operating Cash Flow | -$37 | -$60 | -$71 | -$72 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | -$0 | -$0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | $0 | -$30 | $10 |
| Stock Issued | $2 | $28 | $53 | $20 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $38 | $3 | $26 |
| Financing Cash Flow | $2 | $66 | $27 | $56 |
| Forex Effect | -$0 | -$0 | -$0 | -$0 |
| Net Chg. in Cash | -$35 | $6 | -$45 | -$16 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48 | $42 | $86 | $102 |
| End Cash | $13 | $48 | $42 | $86 |
| Free Cash Flow | -$37 | -$60 | -$71 | -$72 |